Prospective comparison of simultaneous [68Ga]Ga-PSMA-11 PET/MR versus PET/CT in patients with biochemically recurrent prostate cancer.

Sander JentjensCindy MaiNiloefar Ahmadi BidakhvidiLiesbeth De CosterNathalie MertensMichel KooleWouter EveraertsSteven JoniauRaymond OyenKoen Van LaereKarolien Goffin

Published in: European radiology (2021)

• PSMA PET/MRI detects the location of biochemical recurrence at least as accurately as PET/CT. • Substitution of PET/CT by PET/MRI adds sensitivity in PSMA lesion detection also in the setting of distant recurrence due to both the MR and TOF PET components.

Keyphrases

pet ct
contrast enhanced
prostate cancer
positron emission tomography
magnetic resonance imaging
computed tomography
mass spectrometry
diffusion weighted imaging
lymph node
free survival
loop mediated isothermal amplification